Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 3/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | CASP2 | P42575 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6762129 | 0.82 | DNM1 (0.57) | — | |
| SCHEMBL8083797 | 0.82 | DNM1 (0.57) | — | |
| Miramistin Ion SCHEMBL2238282 | 0.81 | DNM1 (0.62) | EPHX2HPGD | |
| SCHEMBL11305761 | 0.81 | DNM1 (0.62) | EPHX2HPGD | |
| SCHEMBL10034064 | 0.81 | DNM1 (0.62) | EPHX2HPGD | |
| Hydrochloric Acid SCHEMBL29729671 | 0.80 | MEN1 (0.58) | HDAC1HDAC8 | |
| Hydrochloric Acid SCHEMBL30869258 | 0.80 | MEN1 (0.58) | HDAC1HDAC8 | |
| Water SCHEMBL11790520 | 0.80 | DNM1 (0.55) | HDAC1HDAC8 | |
| Hydrochloric Acid SCHEMBL1123490 | 0.80 | MEN1 (0.58) | HDAC1HDAC8 | |
| Miramistin Ion SCHEMBL23922700 | 0.80 | MEN1 (0.62) | EPHX2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9802908-B2 | Ethyl benzyl quaternary amines of amido amines for improved antifungal properties | TPAT IP LLC | 2017-10-31 | — | — | US | disclosed |
| US-20160176802-A1 | Ethyl Benzyl Quaternary Amines of Amido Amines for Improved Antifungal properties | TPAT IP LLC | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160176802-A1 | Ethyl Benzyl Quaternary Amines of Amido Amines for Improved Antifungal properties | BET1, ASNS, NAAA | MTNR1A 4115/4885EPHX2 3435/4885HPGD 4132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.